Omneity® Pellets
All-In-One Vitamin & Mineral Pellet
Topic:Medication
The topic of medication in horses encompasses the study and application of pharmaceutical substances used to treat, manage, or prevent diseases and conditions in equine patients. This field involves understanding the pharmacokinetics and pharmacodynamics of various drugs, including their absorption, distribution, metabolism, and excretion in horses. Medications commonly administered to horses include non-steroidal anti-inflammatory drugs (NSAIDs), antibiotics, anthelmintics, and sedatives. The appropriate use of these medications is critical for ensuring therapeutic efficacy and minimizing adverse effects. Research in this area focuses on dosage optimization, drug interactions, resistance development, and withdrawal times to ensure both the health of the horse and compliance with regulatory standards. This page aggregates peer-reviewed studies and scholarly articles that explore the pharmacological aspects, clinical applications, and regulatory considerations of equine medications.
Phenoxymethyl penicillin in the horse: an alternative to parenteral administration of penicillin. This preliminary study evaluated phenoxymethyl penicillin (Penicillin V) as an alternative to parenteral administration of penicillin in horses. Penicillin V was administered orally to five horses at two different doses and plasma levels of the drug were determined at timed intervals. The results were evaluated by regression analysis. Following the administration of penicillin V at a dose of 66,000 IU/kg or 110,000 IU/kg, the mean peak plasma levels obtained were 1.55 micrograms/mL and 2.34 micrograms/mL respectively. A plasma level two to four times above the minimal inhibitory concentration ...
Ivermectin: a potent new antiparasitic agent. Ivermectin is the 22,23-dihydro derivative of avermectin B1, a macrocyclic lactone produced by an actinomycete, Streptomyces avermitilis. It is active at extremely low dosage against a wide variety of nematode and arthropod parasites, apparently by virtue of its action on the mediation of neurotransmission by gamma-aminobutyric acid. It is now in commercial use in various countries for the treatment and control of parasites in cattle, horses, and sheep, and is expected to become available for use in swine and dogs. Since studies with the drug in man are in a preliminary stage, it is not yet kn...
[The treatment of a lung worm infection in ponies with albendazole (Valbazen)]. A report on infection with Dictyocaulus arnfieldi in a number of ponies and one horse in which complete clinical recovery was obtained following treatment with albendazole (Valbazen), administered by oral route at a dosage of 25 mg/kg of body weight twice daily for five days.
Native American medicinal plants. Anemonin from the horse stimulant Clematis hirsutissima. Anemonin, the dilactone of cyclobutane-1,2-diol-1,2-diacrylic acid derived from the cyclodimerization of protoanemonin, a known blistering agent, was isolated from Clematis hirsutissima, a plant used by the Nez Perce and Teton Sioux nations as a horse stimulant.
Biochemical and haematological effects of a revised dosage schedule of phenylbutazone in horses. Five pairs of matched horses were used to study the biochemical and haematological effects of a revised dosage schedule of phenylbutazone. One group of five horses received a phenylbutazone paste formulation daily for 12 days and a second group of five animals received a placebo preparation for a similar time. Some statistically significant differences were recorded from pretreatment levels in both groups of horses. These changes represented instability in baseline levels and could not be ascribed to phenylbutazone administration.
Influence of acepromazine maleate on the equine haematocrit. The effect of acepromazine maleate (ACP) on the equine venous haematocrit and total plasma protein concentration was studied in six clinically normal horses. Total plasma protein concentration was not appreciably influenced by ACP. However, the haematocrit decreased with the duration, but not the degree, of the decrease being dose-related. Mean haematocrit values returned to control levels by 12 h after 0.05 mg ACP/kg body weight and 21 h after 0.15 mg ACP/kg body weight.
The pharmacology of furosemide in the horse. V. Pharmacokinetics and blood levels of furosemide after intravenous administration. Studies were undertaken to determine blood levels of furosemide in horses after 0.5- and 1.0-mg/kg doses administered iv. Analyses indicated that the pharmacokinetic parameters were dose independent and best described by a three-compartment open model. The alpha-, beta-, and gamma-phase half-lives of 5.6, 22.3, and 158.5 min, respectively, were observed after the 0.5-mg/kg dose. Similarly, the respective half-lives after the 1.0-mg/kg dose were 5.8, 24.1, and 177.2 min. After a 0.5-mg/kg dose of furosemide, population frequency distributions were evaluated at 1 hr and 4 hr post-drug administra...
Synthesis and properties of equine beta-melanotropin analogs with substitution in residue position 1. Five analogs of equine β-melanotropin have been synthesized by the solid phase method. The NH2-terminal aspartic acid was substituted with amino acids (Gly, Trp, Ile, Lys and Nα-acetyl-Asp) differing widely in physicochemical properties. On the basis of their lipolytic potencies it was concluded that this position plays a negligible role in this activity.
Pre-race testing and its role in equine medication control. In general, blood is the only material on which a practical pre-race testing scheme can be based. Blood testing is not as sensitive as urine testing and detects only about 66 per cent of the drugs detectable in urine. Therefore, pre-race blood testing is always performed in conjunction with post race urine testing. Because blood is easily and rapidly drawn, the use of blood samples in all post race testing schemes is recommended. Pre-race testing is also a relatively expensive proposition, but it is the only method which actually prevents the running of an illegally medicated horse.
Cutaneous onchocerciasis in the horse: five cases in southwestern british columbia. Five horses were presented because of a dermatitis of the forehead. Unlike previous reports, ventral midline dermatitis was not the major problem, and was present in only two of five cases. All five horses responded to levamisole therapy at a daily dosage of 5.5 g for one week. Owners were cautioned that repeat therapy may be necessary.
Controlled tests of pastes of dichlorvos and thiabendazole against induced Strongyloides westeri infections in pony foals in 1973-1974. In 1973-1974, 4 controlled tests were performed in pony foals (n = 17) raised parasite-free and experimentally infected with Strongyloides westeri. Administration of infective larvae by stomach tube in 1 test resulted in low-grade infections and tended to invalidate the test. Intraoral and percutaneous (intra-aural) administration of larvae resulted in suitable test infections for 1 and 2 tests, respectively. A paste formulation of dichlorvos at 36.3 mg/kg of body weight removal from 4 ponies. Treatment of 4 the dosage rate of 44 mg/kg was consistently effective (greater than 99% to 100%) for ...
